Mary Z. Luo, COO, Chief Scientist & Chairman, CEO & Chief Scientific Officer at Amphastar Pharmaceuticals, Inc. (AMPH), sold 439,600 shares at $63.27 ($25.6M) on 2024-01-08, disclosed to the SEC on 2024-01-10.
Scheduled sale ($25.6M) by COO, Chief Scientist & Chairman, CEO & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.98 | 18,858 | $1.1M | 4.2% |
| 2 | $56.98 | 18,858 | $1.1M | 4.2% |
| 3 | $58.25 | 41,282 | $2.4M | 9.4% |
| 4 | $58.25 | 41,282 | $2.4M | 9.4% |
| 5 | $59.24 | 37,865 | $2.2M | 8.8% |
| 6 | $59.24 | 37,865 |
| $2.2M |
| 8.8% |
| 7 | $59.99 | 27,563 | $1.7M | 6.5% |
| 8 | $59.99 | 27,563 | $1.7M | 6.5% |
| 9 | $61.19 | 4,261 | $261K | 1.0% |
| 10 | $61.19 | 4,261 | $261K | 1.0% |
| 11 | $61.81 | 1,663 | $103K | 0.4% |
| 12 | $61.81 | 1,663 | $103K | 0.4% |
| 13 | $63.27 | 2,152 | $136K | 0.5% |
| 14 | $63.27 | 2,152 | $136K | 0.5% |
| 15 | $56.70 | 50,678 | $2.9M | 11.2% |
| 16 | $56.70 | 50,678 | $2.9M | 11.2% |
| 17 | $57.70 | 31,764 | $1.8M | 7.2% |
| 18 | $57.70 | 31,764 | $1.8M | 7.2% |
| 19 | $58.35 | 3,714 | $217K | 0.8% |
| 20 | $58.35 | 3,714 | $217K | 0.8% |
| Total | $58.23 avg | 439,600 | $25.6M | 100% |
| Filing → |
| AMPH | SELL | 2019-09-12 | $6.2M | — | Filing → |
| AMPH | SELL | 2018-12-13 | $5.7M | — | Filing → |
| AMPH | SELL | 2015-12-11 | $902K | — | Filing → |